Publications by authors named "Nora Chiang"

30Publications

Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.

Drug Metab Dispos 2019 07 16;47(7):690-698. Epub 2019 Apr 16.

National Institutes of Health, National Institute on Drug Abuse, Bethesda, Maryland (P.K., C.N.C., S.G., P.S.); and Sekisui XenoTech, LLC, Kansas City, Kansas (R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.118.085977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548978PMC
July 2019

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.

J Clin Pharmacol 2019 08 12;59(8):1078-1084. Epub 2019 Mar 12.

National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606390PMC
August 2019

A cholecystokinin B receptor antagonist and cocaine interaction, phase I study.

CNS Neurosci Ther 2019 01 20;25(1):136-146. Epub 2018 Jun 20.

Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cns.12994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309275PMC
January 2019

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.

Drug Alcohol Depend 2016 Sep 28;166:13-20. Epub 2016 May 28.

Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2016.05.019DOI Listing
September 2016

Modafinil for the treatment of methamphetamine dependence.

Drug Alcohol Depend 2012 Jan 12;120(1-3):135-41. Epub 2011 Aug 12.

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892-9551, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2011.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227772PMC
January 2012

Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.

Addiction 2011 Mar 6;106(3):499-506. Epub 2010 Dec 6.

Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center, Baltimore, MD 21146, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1360-0443.2010.03228.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461262PMC
March 2011

Modafinil for the treatment of cocaine dependence.

Drug Alcohol Depend 2009 Sep 26;104(1-2):133-9. Epub 2009 Jun 26.

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892-9551, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2009.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818032PMC
September 2009

Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.

J Anal Toxicol 2008 Oct;32(8):562-9

Chemistry and Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587336PMC
http://dx.doi.org/10.1093/jat/32.8.562DOI Listing
October 2008

Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists.

Drug Alcohol Depend 2008 Jan;92(1-3):307-11

Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institute of Health, Bethesda, MD 20892-9551, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2007.05.020DOI Listing
January 2008

Bupropion for the treatment of methamphetamine dependence.

Neuropsychopharmacology 2008 Apr 20;33(5):1162-70. Epub 2007 Jun 20.

Clinical Medical Branch, Division of Pharmacotherapies and Medical Consequences, National Institutes of Health, National Institute on Drug Abuse, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1301481DOI Listing
April 2008

Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosing.

J Addict Med 2007 Jun;1(2):88-95

From the UCLA School of Nursing (PC), Los Angeles, CA; UCLA Integrated Substance Abuse Programs (WL, DL, CC), Los Angeles, CA; Division of Pharmacotherapies and Medical Consequences of Drug Abuse (CNC), National Institute on Drug Abuse, Bethesda, MD; Center for Human Toxicology (DEM), University of Utah, Salt Lake City, UT; and University of Washington (AH), Drug and Alcohol Institute, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ADM.0b013e31806dcc3eDOI Listing
June 2007

Modafinil and cocaine interactions.

Am J Drug Alcohol Abuse 2006 ;32(4):577-87

Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00952990600920425DOI Listing
March 2007

Methylphenidate and cocaine: a placebo-controlled drug interaction study.

Pharmacol Biochem Behav 2006 Sep 17;85(1):29-38. Epub 2006 Aug 17.

Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pbb.2006.06.023DOI Listing
September 2006

Intravenous cocaine and QT variability.

J Cardiovasc Electrophysiol 2006 Jun;17(6):610-6

Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8167.2006.00421.xDOI Listing
June 2006

Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence.

Drug Alcohol Depend 2006 Dec 30;85(3):191-7. Epub 2006 May 30.

National Institute on Drug Abuse (NIDA), Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA), MSC 9551 Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2006.04.010DOI Listing
December 2006

A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline.

Pharmacol Biochem Behav 2005 Dec 18;82(4):704-11. Epub 2006 Jan 18.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at The University of California at Los Angeles, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009130570500372
Publisher Site
http://dx.doi.org/10.1016/j.pbb.2005.11.012DOI Listing
December 2005

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

Neuropsychopharmacology 2006 Jul 23;31(7):1537-44. Epub 2005 Nov 23.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at The University of California at Los Angeles, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1300979DOI Listing
July 2006

Safety of intravenous methamphetamine administration during treatment with bupropion.

Psychopharmacology (Berl) 2005 Nov 19;182(3):426-35. Epub 2005 Oct 19.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00213-005-0102-8
Publisher Site
http://dx.doi.org/10.1007/s00213-005-0102-8DOI Listing
November 2005

Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.

Drug Alcohol Depend 2006 Mar 6;82(1):25-31. Epub 2005 Sep 6.

School of Nursing, University of California at Los Angeles, Factor Building 4-246, Box 956918, Los Angeles, CA 90095-6918, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2005.08.005DOI Listing
March 2006

Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.

Clin Pharmacokinet 2005 ;44(7):753-65

Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003088-200544070-00006DOI Listing
August 2006

Transdermal selegiline and intravenous cocaine: safety and interactions.

Psychopharmacology (Berl) 2004 Feb 6;172(1):31-40. Epub 2003 Nov 6.

Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Bayview Medical Center, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00213-003-1616
Web Search
http://link.springer.com/10.1007/s00213-003-1616-6
Publisher Site
http://dx.doi.org/10.1007/s00213-003-1616-6DOI Listing
February 2004

Pharmacokinetics of the combination tablet of buprenorphine and naloxone.

Drug Alcohol Depend 2003 May;70(2 Suppl):S39-47

Division of Treatment Research and Development, National Institute on Drug Abuse, 6001 Executive Blvd, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0376-8716(03)00058-9DOI Listing
May 2003